VANCOUVER, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG), a dynamic holding company focused on ...
The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid ...
A common cold medicine has been deemed ineffective and will no longer be available for purchase. The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a ...
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After ...
The FDA finalized a rule stating that triclosan and 23 other active ingredients are not “generally recognized as safe and effective for use in over-the-counter healthcare antiseptic products.” The OTC ...
Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain ...
Advisers for the US Food and Drug Administration voted unanimously on Wednesday in support of making the birth-control pill Opill available over-the-counter, saying the benefits outweigh the risks.
Maybe it’s Mucinex or Sudafed that always helps you get over the hump with a nasty cold, or maybe you’re more of a NyQuil person. Whichever cough and decongestant medicine you buy over-the-counter ...
The US Food and Drug Administration (FDA) has announced new action to encourage companies to develop naloxone products for over-the-counter (OTC) use — or apply to switch certain products from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback